Continuing an upward trajectory, BioWorld’s Drug Developers Index (BDDI) has climbed more than 10% since the start of this year, following sharp drops at the end of March and May. Shares began to rebound in June and the index has shown a steady incline, similar with the Nasdaq Biotechnology Index, which is currently up 12%.
With financings falling just shy of last year, the med-tech industry has raised a total of $41.3 billion so far in 2021 through 494 financings. That is down roughly 3% from the 513 financings worth $42.46 billion by this point in 2020. Most of the money last year came through follow-on offerings and private placements, with IPOs and venture capital rounds making up only 26% of the total.
RSS
